DV
Dividend Vision

ACRS — Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (ACRS)

Total return is -47.7% over the past 10.9 years, 412.3 points behind SPY at 364.6%. Its deepest 1-year drawdown was 36.6%.

Aclaris Therapeutics Inc is an individual equity stock, not a diversified ETF, that operates in the pharmaceutical and therapeutics sector. As a single-stock holding, it does not pay dividends and therefore has no yield profile or regular distribution frequency, making it unsuitable for income-focused investors seeking dividend payments. This equity security is primarily relevant to investors seeking exposure to the biotech and pharmaceutical development space who are focused on capital appreciation rather than current income.

ACRS key facts

Asset type
Stock
Asset class
Equity
Inception date
10/07/2015
Last close
$5.78
Market cap
$793,289,664
Average volume
666268.0
Beta
0.769
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.56